Can CBD Treat SARS-CoV-2 Variants? Patent Filings Say Yes
Patent Forecast has highlighted in two insights (Can CBD Obliterate COVID Variants? Hello Nasal Spray & Were You Exposed to COVID-19? Here’s What You Could Do Next.) the increase in filings for treating COVID-19 with cannabinoids, specifically pure cannabidiol (CBD). While research has been inconclusive, laboratory tests have shown in vitro and in mice that CBD could be effective in preventing replication of SARS-CoV-2 in cells. This has commenced clinical trials and increased patent filings in the space especially as new variants circulate and test the efficacy of the COVID-19 vaccine.
The latest patent application to surface was applied for by Western Star Management LLC, which appears to be operating in stealth mode. The claims describe reducing circulating levels of pro-inflammatory cytokines tumor necrosis factor-alpha and interleukin 6 (IL-6) in human patients by 25-50% through a full spectrum composition consisting of at least 70% CBD, 3% CBDV, 2% THCV, and 1 % THC. This composition has to be administered for at least 20 days and is claimed to be effective toward Type II diabetes and improving sleep. Recent research has shown that THC could block CBD’s antiviral activity, so it will be interesting to see whether this application can make it to the market. What is certain is that patent investment precedes market activity.
The future of cannabinoids being used to treat SARS-CoV-2 among other disorders and diseases will rely solely on the results of the clinical tests and trials as GW Pharmaceuticals’ Epidolex experienced. Correlation has been made between people prescribed CBD for epilepsy and reduced COVID-19 infections in this population. Keep up with the cannabinoid for infections scene through the Cannabis Patent Forecast®. Find patent assets covering the aforementioned treatments in the ‘Medications – Respiratory’ and ‘Medications – Immune’ categories.
Related Posts
May 20, 2021
Cannabis Popularity Soars Along With Tests To Detect It
The Duquenois Levine Test is used in the field by law enforcement officers to test for THC presence in a suspected sample. The problem with…
April 15, 2021
Hound Labs, Cannabix and Vox Heat Up the Marijuana Breathalyzer Market
At the start of April 2021, Patent Forecast® released an insight going over some of the big name competitors getting their foot in the door…
April 8, 2021
Driving While High? Cannabis Sobriety Testing Heats Up
What’s the future of cannabis innovation? We see things before they happen using our Patent Forecast®. One of those is the development of…